Vanguard Capital Management’s LB Pharmaceuticals LBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LBRX
Vanguard Capital Management's LBRX Position: Q3 2026 in Review
Vanguard Capital Management increased its LB Pharmaceuticals (LBRX) stake by 13% in Q3 2026, buying an estimated $5.32M and bringing the position to 1,099,880 shares worth $42.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.
Vanguard Capital Management first reported a position in LBRX in Q1 2026 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.
- Vanguard Capital Management held 1,099,880 shares of LB Pharmaceuticals worth $42.2M as of Q3 2026.
- Vanguard Capital Management bought 128,715 LB Pharmaceuticals shares in Q3 2026, an estimated $5.32M.
- LB Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1983 holding.
- Vanguard Capital Management first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 147 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.